Etchegary Holly, Dicks Elizabeth, Hodgkinson Kathleen, Pullman Daryl, Green Jane, Parfey Patrick
Department of Clinical Epidemiology, Faculty of Medicine, Eastern Health and Memorial University, St. John's, NL, Canada..
Department of Clinical Epidemiology, Faculty of Medicine, Eastern Health, St. John's, NL, Canada.
J Obstet Gynecol Neonatal Nurs. 2012 Mar;41(2):191-200. doi: 10.1111/j.1552-6909.2012.01341.x.
To measure attitudes toward newborn genetic testing in our jurisdiction.
A cross-sectional, pen-and-paper survey.
The survey was administered to the general public and prospective parents in Eastern Canada between April 2010 and December 2010.
A total of 648 individuals completed surveys.
Positive attitudes were found toward newborn genetic testing, regardless of whether an effective treatment existed for the disorder in question or whether the disorder developed in adulthood. A majority agreed (69%) that testing should be available for any condition to assist with future reproductive decisions. Most respondents (93%) agreed parents should provide informed consent before newborn screening (NBS) was undertaken and that parents had a fundamental right to access NBS if they so choose.
Interest in NBS for genetic disorders is generally high, regardless of whether an effective treatment exists. Findings lend support to the expansion of NBS panels to include those disorders currently lacking treatment but highlight consumers' desire for informed consent before testing is undertaken.
衡量我们辖区内对新生儿基因检测的态度。
一项横断面纸笔调查。
2010年4月至2010年12月期间,对加拿大东部的普通公众和准父母进行了此项调查。
共有648人完成了调查。
无论所涉疾病是否有有效治疗方法,也无论该疾病是否在成年期发病,对新生儿基因检测均持积极态度。大多数人(69%)同意,应针对任何疾病进行检测,以协助未来的生育决策。大多数受访者(93%)同意,在进行新生儿筛查(NBS)之前,父母应提供知情同意书,并且父母如果愿意,有权进行NBS。
无论是否存在有效治疗方法,对遗传性疾病进行NBS的兴趣普遍较高。研究结果支持扩大NBS检测项目,将目前缺乏治疗方法的疾病纳入其中,但也凸显了消费者在进行检测前对知情同意的渴望。